The aim of the present study was to analyze, in patients admitted for HHC, the risk factors for the occurrence of hypoglycemia and the mid- and long-term prognostic value of hypoglycemia during the treatment of HHC, both in the IIITP and in the later subcutaneous insulin therapy phase (LSITP). Here, INS is linked to Hypoglycemia.